1. Home
  2. EVI vs FHTX Comparison

EVI vs FHTX Comparison

Compare EVI & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVI
  • FHTX
  • Stock Information
  • Founded
  • EVI 1959
  • FHTX 2015
  • Country
  • EVI United States
  • FHTX United States
  • Employees
  • EVI N/A
  • FHTX N/A
  • Industry
  • EVI Other Consumer Services
  • FHTX Medicinal Chemicals and Botanical Products
  • Sector
  • EVI Consumer Discretionary
  • FHTX Health Care
  • Exchange
  • EVI Nasdaq
  • FHTX Nasdaq
  • Market Cap
  • EVI 268.8M
  • FHTX 278.1M
  • IPO Year
  • EVI N/A
  • FHTX 2020
  • Fundamental
  • Price
  • EVI $23.70
  • FHTX $4.90
  • Analyst Decision
  • EVI Strong Buy
  • FHTX Strong Buy
  • Analyst Count
  • EVI 1
  • FHTX 8
  • Target Price
  • EVI $28.00
  • FHTX $12.63
  • AVG Volume (30 Days)
  • EVI 10.0K
  • FHTX 117.8K
  • Earning Date
  • EVI 09-11-2025
  • FHTX 08-05-2025
  • Dividend Yield
  • EVI 1.33%
  • FHTX N/A
  • EPS Growth
  • EVI 29.85
  • FHTX N/A
  • EPS
  • EVI 0.48
  • FHTX N/A
  • Revenue
  • EVI $370,020,000.00
  • FHTX $24,173,000.00
  • Revenue This Year
  • EVI $10.08
  • FHTX $33.60
  • Revenue Next Year
  • EVI $13.58
  • FHTX $5.87
  • P/E Ratio
  • EVI $48.54
  • FHTX N/A
  • Revenue Growth
  • EVI 3.51
  • FHTX N/A
  • 52 Week Low
  • EVI $14.51
  • FHTX $2.95
  • 52 Week High
  • EVI $27.69
  • FHTX $10.25
  • Technical
  • Relative Strength Index (RSI)
  • EVI 53.63
  • FHTX 39.80
  • Support Level
  • EVI $20.85
  • FHTX $4.82
  • Resistance Level
  • EVI $24.43
  • FHTX $5.24
  • Average True Range (ATR)
  • EVI 1.08
  • FHTX 0.42
  • MACD
  • EVI -0.22
  • FHTX -0.19
  • Stochastic Oscillator
  • EVI 61.29
  • FHTX 8.92

About EVI EVI Industries Inc.

EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: